Clinical Trial Update: A Study to Qualify an In-house Reference Standard Batch of Sci-B-Vac™ [Phase 4]

View source ↗

Summary

Phase 4 trial updating qualification of an in-house reference standard batch for Sci-B-Vac, with Hepatitis B as the indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Sci-B-Vac (hepatitis B vaccine (recombinant))

Snippet

Sponsor: VBI Vaccines Inc. | Conditions: Hepatitis B | Phase 4 | Status: COMPLETED | Results posted: 2022-06-24